Concepedia

Andrés Digenio

AD

Statistics

Publications

38

Citations

3.9K

H-Index

22

Active since

1989

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Akebia Therapeutics (United States)

Sanofi (United States)

Pfizer (United States)

University of California San Diego

Andrés Digenio is an author at Ionis Pharmaceuticals (United States) specializing in medicine, clinical pharmacology, and pharmacology.

Publications per year

1989–2019

38

Publications

38

Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol

Margaret E. Brousseau, Ernst J. Schaefer, Megan L. Wolfe et al. · New England Journal of Medicine · 2004 · 777 citations · Full text

, , +13

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

Joseph L. Witztum, Daniel Gaudet, Steven D. Freedman et al. · New England Journal of Medicine · 2019 · 669 citations · Full text

, , +17

Cardiovascular and Metabolic Effects of <i>ANGPTL3</i> Antisense Oligonucleotides

Mark J. Graham, Richard Lee, Teresa Brandt et al. · New England Journal of Medicine · 2017 · 581 citations · Full text

, , +14

Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion

Margaret E. Brousseau, Margaret R. Diffenderfer, John S. Millar et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 233 citations

, , +15

Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes

Matthew C. Riddle, Guillermo E. Umpierrez, Andrés Digenio et al. · Diabetes Care · 2011 · 217 citations · Full text

, , +17

1–5 of 38